Some people are letting their guard down in the face of a Covid-19 variant that appears to cause largely mild illness. Health experts say risks remain.
Hyper-infectiousness and low disease severity convince some of diminished danger; health experts say risks remain
To fight Omicron surges, some countries are handing out second booster shots. In Israel, early data suggest a fourth vaccine dose can increase protection against Covid-19, but scientists aren’t sure how long it can last and some say additional boosters won’t help. Photo composite: Eve Hartley/WSJ
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Covid-19 news: Joint flu and covid-19 vaccine could be offered in 2023Today’s covid-19 news: · Single covid-19 and flu vaccine could be available in 2023, says Moderna CEO · England coronavirus restrictions might end in March · Thousands of hamsters euthanised in Hong Kong following evidence of coronavirus transmission
Les mer »
North Texas COVID-19 surge showing some signs of a plateau, health officials sayHealth officials across North Texas are optimistic we may soon be over the hump in terms of new COVID cases. The state’s positivity rate has declined for three days in a row since Friday. But hospitalizations aren’t showing any sign of going down yet.
Les mer »
COVID-19 health emergency could be over this year, WHO saysThe head of emergencies at the WHO said that the worst of the coronavirus pandemic — deaths, hospitalizations and lockdowns — could be over this year if huge inequities in vaccinations and medicines are addressed quickly.
Les mer »
COVID-19 health emergency could be over this year, WHO saysPublic health officials have warned it is highly unlikely COVID-19 will be eliminated and say it will continue to kill people, though at much lower levels, even after it becomes endemic.
Les mer »
With limited lead time, Mass. private health insurers create new COVID-19 test reimbursement systemsThe federal government says it’s 'strongly incentivizing' insurers to arrange a system where people can get tests with no out-of-pocket costs. But that isn't likely to happen right away in Massachusetts.
Les mer »